Antioxidant supplementation is effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis, according to a new study published in the journal Gastroenterology.
In the placebo-controlled, double-blind trial, 127 patients were assigned to placebo or antioxidant groups. After six months, the reduction in the number of painful days per month was significantly higher in the antioxidant group compared with the placebo group. The reduction in the number of analgesic tablets per month was also higher in the antioxidant group. Furthermore, 32% and 13% of patients became pain free in the antioxidant and placebo groups, respectively; the beneficial effect of antioxidants on pain relief was noted early at three months.
"Abdominal pain, the predominant symptom in patients with CP, is difficult to treat. The main reason for a largely ineffective medical treatment is that the mechanism of pain in CP is not well understood," said lead author Pramod Garg. "We are encouraged by our findings, as significant improvement was noted with antioxidants in respect to all the parameters of pain in this study. In addition, reduction in pain resulted in fewer man-days lost, thus providing functional employment gain to the patients," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze